Efektivitas Terapi Metformin dalam Mencapai Target Kadar HbA1c <7% pada Pasien DMT2 di Puskesmas Imogiri 1:Perspektif Layanan Primer

Authors

  • Ni Kadek Ayu Kunti Pertiwi Universitas Kristen Duta Wacana
  • Lisa Kurnia Sari Universitas Kristen Duta Wacana
  • Hendi Wicaksono Universitas Kristen Duta Wacana
  • Tejo Jayadi Universitas Kristen Duta Wacana

DOI:

https://doi.org/10.55123/sehatmas.v4i4.6349

Keywords:

Metformin, Hba1c, Treatment Adherence, Type 2 Diabetes Mellitus, Glycemic Control

Abstract

Type 2 Diabetes Mellitus (T2DM) is a chronic disease with high prevalence in Indonesia, include Bantul Regency,Yogyakarta. In September 2024 the number of cases reached 18,520, indicating a high disease burden at the primary healthcare level. At Puskesmas Imogiri 1, most T2DM patients receive metformin therapy, yet the coverage of care and effectiveness of treatment in achieving optimal glycemic control, particularly HbA1c levels, remain challenging in daily practice. This study aimed to assess the effectiveness of metformin dosage in achieving HbA1c <7% in T2DM patients at Puskesmas Imogiri 1. A quantitative study with a cross-sectional design and total sampling technique was conducted among T2DM patients treated at this facility. The variables studied included type and dosage of metformin therapy and HbA1c levels as indicators of glycemic control, with data collected from medical record reviews, including medication history and the most recent HbA1c test results. Of the 54 respondents, 35.2% achieved HbA1c <7%, while the majority remained above the target. Statistical analysis using Fisher’s Exact Test revealed no significant association between metformin dosage and glycemic control status. Likewise, duration of therapy, sex, and age were not significantly associated with HbA1c achievement (p>0.05). In conclusion, this study indicates that there is no significant relationship between metformin dosage, duration of therapy, age, or sex and the achievement of HbA1c targets in T2DM patients at Puskesmas Imogiri 1.

Downloads

Download data is not yet available.

References

Abdulrahman, Z. S., Al-Atrakji, M. Q. Y. M. A., Al-Maliky, A. A., Hussein, K. I., & Hussain, S. A. (2023). Influence of metformin dose and treatment adherence on glycemic control, adiposity, and cardiovascular risk markers in Iraqi patients with T2DM. Journal of the Faculty of Medicine Baghdad, 64(4). https://doi.org/10.32007/jfacmedbagdad.6441939

Agnes Silvina Marbun, dkk. (2022). Pelaksanaan Empat Pilar pada Penderita Diabetes Melitus. Jurnal Abdimas Mutiara, 3(1), 366–371.

Amer, B. E., et al. (2024). Metformin plus lifestyle interventions versus lifestyle interventions alone for the delay or prevention of type 2 diabetes in individuals with prediabetes: a meta-analysis. BMC Public Health, PMCID: PMC11562588.

Apriliany, F., Cholisah, E., & Erlianti, K. (2022). Efek pemberian metformin dan metformin + glimepiride terhadap kadar HbA1c pada pasien diabetes mellitus tipe 2. Jurnal Medika Plantae Farmasi, 12(2), 97–106. https://doi.org/10.22146/jmpf.72192

Della, A., Subiyanto, P., & Maria, A. (2023). Faktor-Faktor Yang Berhubungan Dengan Kepatuhan Pengobatan Pasien Diabetes Melitus Tipe 2. Jurnal Keperawatan Klinis Dan Komunitas (Clinical and Community Nursing Journal), 7(2), 124. https://doi.org/10.22146/jkkk.83090

Dinas Kesehatan Kabupaten Bantul. Profil Kesehatan Kabupaten Bantul Tahun 2024 [Internet]. Bantul: Dinas Kesehatan Kabupaten Bantul; 2024 [cited 2024 Dec 4). Available from: https://dinkes.bantulkab.go.id/

Doğan, M. (2018). Is high level of HbA1c an indicator for extended period of antibiotherapy in diabetic foot ulcers? Northern Clinics of Istanbul. https://doi.org/10.14744/nci.2018.25582

Helny Zuraini Tarigan, & Riduan Benny. (2024). Hasil Kadar HbA1C Penderita Diabetes Melitus Tipe 2 Pada Kelompok Prolanis Di Puskesmas Juhar Tahun 2023. Corona: Jurnal Ilmu Kesehatan Umum, Psikolog, Keperawatan Dan Kebidanan, 2(1), 148–153. https://doi.org/10.61132/corona.v2i1.210

Hieshima, K., Sugiyama, S., Yoshida, A., Kurinami, N., Suzuki, T., Miyamoto, F., Kajiwara, K., Jinnouchi, K., Jinnouchi, T., & Jinnouchi, H. (2025). High frequency of defecation under metformin use may be a potential glucose-lowering factor independent of the dose-dependent effect of metformin in patients with type 2 diabetes mellitus. Internal Medicine, 64(10), 1485–1495. https://doi.org/10.2169/internalmedicine.3982-24

International Diabetes Federation. IDF Diabetes Atlas. 11th ed. Brussels: International Diabetes Federation; 2025.

Kementerian Kesehatan Republik Indonesia. Survei Kesehatan Indonesia (SKI) 2023. Jakarta: Kementerian Kesehatan RI; 2023.

Khairun Nisa, Zubir Zubir, & Rizka Sofia. (2025). Profil Kadar HbA1c dan Karakteristik Klinis Pasien Diabetes Melitus Tipe 2 di Poli Penyakit dalam RSUD Cut Meutia Aceh Utara. Jurnal Riset Rumpun Ilmu Kesehatan, 4(1), 299–306. https://doi.org/10.55606/jurrikes.v4i1.4544

Mirghani, H. O. (2017). Distress and psychopathology among Sudanese patients with type 2 diabetes mellitus and its relation to glycaemic control. Journal of Taibah University Medical Sciences, 12(4), 298–303. https://doi.org/10.1016/j.jtumed.2017.02.007

Nikolić, V. N., et al. (2024). Factors contributing to variability in metformin concentration in polycystic ovary syndrome. BMC Pharmacology and Toxicology, PMCID: PMC1107493.

Perdana In draJaya, S., Prijambodo, T., & Wahyu Rahmawati, Y. (2024). Hubungan Dukungan Keluarga dengan Kepatuhan Pengobatan pada Pasien Diabetes Mellitus Tipe 2. Jurnal Ilmiah STIKES Yarsi Mataram, 14(2), 92–99. https://doi.org/10.57267/jisym.v14i2.402

Permissions, G. (2022). 1. Improving Care and Promoting Health in Populations: Standards ofMedical Care in Diabetes—2022. Diabetes Care, 45, S8–S16. https://doi.org/10.2337/dc22-S001

Rasdianah, N., Martodiharjo, S., Andayani, T. M., & Hakim, L. (2016). The Description of Medication Adherence for Patients of Diabetes Mellitus Type 2 in Public Health Center Yogyakarta. Indonesian Journal of Clinical Pharmacy, 5(4), 249–257. https://doi.org/10.15416/ijcp.2016.5.4.249

Rizal, R., & Hariawan, H. (2025). EFEK ANTIDIABETIK ORAL MONOTERAPI DAN KOMBINASI TERHADAP HbA1c PADA PASIEN DIABETES MELITUS TIPE 2 DI WILAYAH KERJA PUSKESMAS NANIA KOTA AMBON. Prepotif : Jurnal Kesehatan Masyarakat, 9(1), 1713–1723. https://doi.org/10.31004/prepotif.v9i1.42106

Sutomo, & Purwanto, N. H. (2023). Pengaruh Konsumsi Tisane Daun Belimbing Wuluh Terhadap Perubahan Kadar Gula dalam Darah pada Penderita Diabetes Mellitus Tipe 2. Jurnal Keperawatan, 146–148.

Syafhan, N. F., et al. (2022). Adherence to metformin in adults with type 2 diabetes: a combined method approach. Journal of Pharmaceutical Policy and Practice, PMCID: PMC9554867.

Xu, Y., Tong, G. Y. Y., & Lee, J. Y.-C. (2020). Investigation on the association between diabetes distress and productivity among patients with uncontrolled type 2 diabetes mellitus in the primary healthcare institutions. Primary Care Diabetes, 14(5), 538–544. https://doi.org/10.1016/j.pcd.2020.04.004

Zhang, X., Wu, H., Fan, B., Shi, M., Lau, E. S. H., Yang, A., Chow, E., Kong, A. P. S., Chan, J. C. N., C. W., R., & Luk, A. O. Y. (2023). The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong Diabetes Surveillance Database of 2 million Chinese adults. The Lancet Regional Health – Western Pacific, 30, 100599. https://doi.org/10.1016/j.lanwpc.2022.100599

Downloads

Published

2025-10-15

How to Cite

Ni Kadek Ayu Kunti Pertiwi, Lisa Kurnia Sari, Hendi Wicaksono, & Tejo Jayadi. (2025). Efektivitas Terapi Metformin dalam Mencapai Target Kadar HbA1c <7% pada Pasien DMT2 di Puskesmas Imogiri 1:Perspektif Layanan Primer. SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat, 4(4), 1179–1186. https://doi.org/10.55123/sehatmas.v4i4.6349